Nutex Health Files Proxy Materials
Ticker: NUTX · Form: DEFA14A · Filed: Jun 27, 2025 · CIK: 1479681
Sentiment: neutral
Topics: proxy-statement, sec-filing, additional-materials
Related Tickers: NUTX
TL;DR
NUTX proxy update filed, shareholders get more info.
AI Summary
Nutex Health, Inc. filed a Definitive Additional Materials proxy statement on June 27, 2025. This filing relates to the company's proxy materials, which were previously filed. The company's principal executive offices are located in Houston, Texas.
Why It Matters
This filing indicates that Nutex Health is providing additional information to shareholders related to a previous proxy statement, likely concerning upcoming shareholder votes or corporate actions.
Risk Assessment
Risk Level: low — This is a routine filing of additional proxy materials, not indicating any new or significant corporate events or risks.
Key Players & Entities
- Nutex Health, Inc. (company) — Registrant
- 0001479681-25-000043 (filing_id) — Accession Number
- 20250627 (date) — Filing Date
- 6030 S. RICE AVE. SUITE C HOUSTON, TX 77081 (address) — Business Address
FAQ
What type of filing is this DEFA14A for Nutex Health, Inc.?
This is a Definitive Additional Materials filing, indicating it supplements previously filed proxy materials.
When was this filing made?
The filing was made on June 27, 2025.
What is the company's primary business address?
The company's business address is 6030 S. Rice Ave., Suite C, Houston, TX 77081.
What was Nutex Health, Inc. formerly known as?
Nutex Health, Inc. was formerly known as Clinigence Holdings, Inc. and iGambit, Inc.
What is the SEC file number for this filing?
The SEC file number is 001-41346.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on June 27, 2025 regarding Nutex Health, Inc. (NUTX).